Ravi Salgia to Mammary Neoplasms, Experimental
This is a "connection" page, showing publications Ravi Salgia has written about Mammary Neoplasms, Experimental.
Connection Strength
0.340
-
Prevention of mammary carcinogenesis in MMTV-neu mice by targeting RLIP. Mol Carcinog. 2021 03; 60(3):213-223.
Score: 0.181
-
Synergistic efficacy of RLIP inhibition and 2'-hydroxyflavanone against DMBA-induced mammary carcinogenesis in SENCAR mice. Mol Carcinog. 2019 08; 58(8):1438-1449.
Score: 0.160